恩威医药 (301331.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(恩威医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 560,341,100.40388,149,545.27183,475,935.51785,191,289.82569,885,071.76395,248,359.56200,800,387.47
 营业收入(元) 560,341,100.40388,149,545.27183,475,935.51785,191,289.82569,885,071.76395,248,359.56200,800,387.47
二、营业总成本(元) 534,869,746.20365,609,056.27174,117,084.98698,325,008.56497,376,667.73332,471,371.23168,140,196.62
 营业成本(元) 274,836,889.56186,797,596.5691,259,994.06382,740,660.83281,555,813.85192,538,531.3294,153,241.28
 研发费用(元) 5,770,697.033,367,770.051,617,199.7216,816,103.7014,966,254.028,067,744.392,127,675.84
 营业税金及附加(元) 9,447,037.166,466,080.532,539,956.5210,892,795.007,600,231.625,286,497.342,764,536.66
 销售费用(元) 187,705,109.10132,079,798.4660,898,593.76234,852,089.62159,371,926.26104,734,981.5959,019,548.45
 管理费用(元) 58,126,682.5537,261,675.1418,208,330.9759,434,237.1339,282,665.7925,501,855.4211,951,249.51
 财务费用(元) -1,016,669.20-363,864.47-406,990.05-6,410,877.72-5,400,223.81-3,658,238.83-1,876,055.12
  其中:利息费用(元) 1,476,158.26568,769.37144,375.00----
  其中:利息收入(元) 2,831,648.231,236,062.81590,393.236,561,772.805,527,944.983,765,158.501,936,297.59
三、其他经营收益
 加:投资收益(元) 2,400,428.631,848,863.591,057,229.313,743,018.062,877,223.942,059,273.881,065,912.13
  其中:对联营企业和合营企业的投资收益(元) -43,542.016,016.68-21,842.4911,550.503,995.80-
 资产处置收益(元) -166,771.50-121,924.03-78,567.23-40,980.60-41,203.90-41,203.90-41,203.90
 资产减值损失(元) -1,225,604.44-1,179,122.47-538,016.26-179,522.93109,991.15-22,214.36-39,381.04
 信用减值损失(元) -511,935.99-1,681,667.22-383,154.61-403,351.04-1,594,285.32-1,212,786.00-682,514.46
 其他收益(元) 2,565,868.931,942,458.741,076,220.5211,741,418.1511,013,570.4810,440,308.111,174,435.23
四、营业利润(元) 28,533,339.8323,349,097.6110,492,562.26101,726,862.9084,873,700.3874,000,366.0634,137,438.81
 加:营业外收入(元) 211,685.686,121.20-284,475.49276,529.2310,073.5710,073.57
 减:营业外支出(元) 3,222,443.46417,364.05571.95696,590.6318,592.7618,089.44-
五、利润总额(元) 25,522,582.0522,937,854.7610,491,990.31101,314,747.7685,131,636.8573,992,350.1934,147,512.38
 减:所得税费用(元) 3,500,619.475,003,412.032,068,060.3215,002,472.5512,196,646.7410,030,308.276,477,882.62
六、净利润(元) 22,021,962.5817,934,442.738,423,929.9986,312,275.2172,934,990.1163,962,041.9227,669,629.76
(一)按经营持续性分类
  持续经营净利润(元) 22,021,962.5817,934,442.738,423,929.9986,312,275.2172,934,990.1163,962,041.9227,669,629.76
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 22,021,962.5817,934,442.738,423,929.9986,312,275.2172,934,990.1163,962,041.9227,669,629.76
 扣除非经常性损益后的净利润(元) 20,443,049.9115,174,473.866,680,192.8973,584,999.3960,980,131.7853,383,576.2825,793,201.95
七、每股收益
 一、基本每股收益(元) 0.220.180.121.231.040.910.39
 二、稀释每股收益(元) 0.220.180.121.231.040.910.39
九、综合收益总额(元) 22,021,962.5817,934,442.738,423,929.9986,312,275.2172,934,990.1163,962,041.9227,669,629.76
 归属于母公司所有者的综合收益总额(元) 22,021,962.5817,934,442.738,423,929.9986,312,275.2172,934,990.1163,962,041.9227,669,629.76
公告日期 2024-10-242024-08-302024-04-222024-04-222023-10-272023-08-282023-04-22
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院